Sonnet BioTherapeutic News

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaDec 9 16:05 ET

Express News | Sonnet BioTherapeutics Announces $3.9M Registered Direct Offering And Concurrent Private Placement, Selling 1.76M Shares And Warrants Priced At-The-Market Under Nasdaq Rules With $2.23 Combined Price And $2.10 Warrant Exercise Price

BenzingaDec 9 15:43 ET

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswireDec 9 15:42 ET

Sector Update: Health Care Stocks Edge Higher Monday Afternoon

MT NewswiresDec 9 13:48 ET

Sector Update: Health Care

MT NewswiresDec 9 13:30 ET

Sonnet BioTherapeutics Shares Are Trading Higher After the Company Announced the Highest Dose of Its Phase 1 SB101 Trial Results for SON-1010 Have Been Formally Evaluated by the Safety Review Committee, With the Maximum Tolerated Dose Set at 1200ng/kg.

BenzingaDec 9 10:57 ET

Trending Stocks Today | LeddarTech Surges 422.24%

Moomoo NewsDec 9 09:50 ET

Sonnet BioTherapeutics Says Phase 1 Trial of SON-1010 Shows Partial Tumor Response, Disease Stabilization

MT NewswiresDec 9 09:28 ET

Express News | Sonnet Biotherapeutics Holdings Inc - Update on Safety at Mtd Expected in Q1 2025

ReutersDec 9 08:45 ET

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

GlobeNewswireDec 9 08:45 ET

Express News | Sonnet Biotherapeutics Announces Topline Safety Data Following Successful Completion of Son-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

ReutersDec 9 08:45 ET

Express News | Sonnet BioTherapeutics Publishes Key Data On SON-1010 IL-12 Fusion Protein In Frontiers In Immunology, Highlighting Mechanism Of Action And Enhanced Tumor Targeting With Patents Secured Through 2039

BenzingaDec 4 09:21 ET

Sonnet BioTherapeutics Releases Virtual Investor '"What This Means" Segment

GlobeNewswireNov 12 09:15 ET

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswireNov 6 13:20 ET

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

BenzingaNov 6 12:47 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaNov 6 11:34 ET

Trending Stocks Today | FOXO Technologies Surges 172.81%

Moomoo NewsNov 6 10:05 ET

Express News | Sonnet BioTherapeutics Shares Resume Trade

BenzingaNov 6 09:42 ET

Express News | Sonnet BioTherapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 106.9%

BenzingaNov 6 09:34 ET

Sonnet BioTherapeutics Announces Issuance Of U.S. Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

BenzingaNov 6 08:33 ET